SHR-7367

· Shanghai Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHR-7367, covering 2025-08-05 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors [Phase 1, Phase 2]